Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 3.37
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Zenith Healthcare Ltd. engages in the manufacture of pharmaceuticals formulation in the forms of tablets, capsules, oral liquids and injections. Its products include antibiotics and anti-infectives, cardiovascular system, central nervous system, gastrointestinal tract, musculo skeletal disorder, respiratory system, genito urinary system, nutrition, skin and endocrine system. The company was founded by Mahendra C. Raycha on...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA.
Data is available to registered users only
Buy
Sell